Publicaciones (60) Publicaciones en las que ha participado algún/a investigador/a

2016

  1. A new strategy to tackle severe knee osteoarthritis: Combination of intra-articular and intraosseous injections of Platelet Rich Plasma

    Expert Opinion on Biological Therapy, Vol. 16, Núm. 5, pp. 627-643

  2. Antidotes for the new oral anticoagulants: Reality and expectations

    Medicina Clinica, Vol. 146, Núm. 11, pp. 488-490

  3. Are we closer to cardiac regeneration?

    Stem Cell Investigation, Vol. 2016, Núm. OCT

  4. Assessment of minimal residual disease in myeloma and the need for a consensus approach

    Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 21-25

  5. Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies

    Cancer, Vol. 122, Núm. 14, pp. 2178-2185

  6. Cancer Immunosurveillance Caught in the Act

    Immunity

  7. Cancer screening after unprovoked venous thrombosis

    The Lancet Oncology

  8. Catheter-based intramyocardial injection of FGF1 or NRG1-loaded MPs improves cardiac function in a preclinical model of ischemia-reperfusion

    Scientific Reports, Vol. 6

  9. Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial

    Annals of Hematology, Vol. 95, Núm. 6, pp. 893-899

  10. Combination of Intra-Articular and Intraosseous Injections of Platelet Rich Plasma for Severe Knee Osteoarthritis: A Pilot Study

    BioMed Research International, Vol. 2016

  11. Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition

    Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 26-30

  12. Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting

    Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 31-39

  13. Correlation between anti-PD-L1 tumor concentrations and tumor-specific and nonspecific biomarkers in a melanoma mouse model

    Oncotarget, Vol. 7, Núm. 47, pp. 76891-76901

  14. Documento multidisciplinar de consenso sobre el manejo de la hemorragia masiva (documento HEMOMAS)

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 63, Núm. 1, pp. e1-e22

  15. Efficacy of Alteplase in a Mouse Model of Acute Ischemic Stroke: A Retrospective Pooled Analysis

    Stroke, Vol. 47, Núm. 5, pp. 1312-1318

  16. Emerging therapies for acute intermittent porphyria

    Expert Reviews in Molecular Medicine, Vol. 18

  17. European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

    Haematologica

  18. Generation and characterization of human iPSC line generated from mesenchymal stem cells derived from adipose tissue

    Stem Cell Research, Vol. 16, Núm. 1, pp. 20-23

  19. Generation and characterization of human iPSC lines derived from a Primary Hyperoxaluria Type I patient with p.I244T mutation

    Stem Cell Research, Vol. 16, Núm. 1, pp. 116-119

  20. Generation of iPSC from cardiac and tail-tip fibroblasts derived from a second heart field reporter mouse

    Stem Cell Research, Vol. 16, Núm. 3, pp. 617-621